Ultralife
ULBI
30 hedge funds and large institutions have $19.9M invested in Ultralife in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
0% less capital invested
Capital invested by funds: $20M → $19.9M (-$99.9K)
1.42% less ownership
Funds ownership: 27.09% → 25.67% (-1.4%)
3% less funds holding
Funds holding: 31 → 30 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$822K |
| 2 |
VWA
Visionary Wealth Advisors
O'fallon,
Illinois
|
+$169K |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$60.5K |
| 4 |
SAM
Shikiar Asset Management
New York
|
+$35.5K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$19.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
-$1.85M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$102K |
| 3 |
TA
Teton Advisors
Rye,
New York
|
-$70.9K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$61K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11.8K |
ULBI Hedge Fund Activity: Q3 2022 in Review
30 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Ultralife (ULBI) for Q3 2022, worth a combined $19.9M — down 0.5% from $20M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ULBI and 4 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 7 added.
The largest buyer was Morgan Stanley, adding an estimated $822K. The largest seller was Monarch Partners Asset Management, exiting entirely with an estimated $1.85M sold.
- 30 institutional investors held Ultralife (ULBI) as of Q3 2022, down from 31 in Q2 2022.
- Funds reported $19.9M of Ultralife stock for Q3 2022, down 0.5% quarter-over-quarter.
- 4 funds opened new Ultralife positions in Q3 2022 and 5 closed out, a net change of -1 holder.
- The largest Ultralife buyer in Q3 2022 was Morgan Stanley, an estimated $822K added.
- The largest Ultralife seller in Q3 2022 was Monarch Partners Asset Management, an estimated $1.85M sold.
Based on aggregated 13F filings for Q3 2022.